Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2025 Filed Dec 2, 2025 15:22 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 5,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054616 · wk-form4_1764688948.xml · nonDerivative · entry 3 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 15:22 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 676 | $17.22 | $11,640.72 |
DisclosureSEC source: 0001628280-25-054616 · wk-form4_1764688948.xml · nonDerivative · entry 2 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,445 F2 · kind: Shares withheld for tax purposes. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 15:22 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 2,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054616 · wk-form4_1764688948.xml · nonDerivative · entry 1 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 15:24 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-045309 · wk-form4_1760714653.xml · derivative · entry 3 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,976 Underlying: Common Stock · 4,976 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on October 15, 2024 and vest in two tranches on the first and second anniversaries of the grant date and the grantee's provision of two periods of credited service F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 15:24 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 1,212 | $20.69 | $25,076.28 |
DisclosureSEC source: 0001628280-25-045309 · wk-form4_1760714653.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,496 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 15:24 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 4,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-045309 · wk-form4_1760714653.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 15:54 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-045313 · wk-form4_1760716493.xml · derivative · entry 3 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,331 Underlying: Common Stock · 9,330 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on October 15, 2024 and vest in two tranches on the first and second anniversaries of the grant date and the grantee's provision of two periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 15:54 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 3,339 | $20.69 | $69,083.91 |
DisclosureSEC source: 0001628280-25-045313 · wk-form4_1760716493.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,699 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 15:54 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-045313 · wk-form4_1760716493.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| September 15, 2025 Filed Sep 16, 2025 14:12 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 483 | $0.00 | $0.00 |
DisclosureSEC source: 0001992434-25-000004 · wk-form4_1758031948.xml · derivative · entry 3 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 498 Underlying: Common Stock · 483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on September 15, 2023 and vest in three tranches on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| September 15, 2025 Filed Sep 16, 2025 14:12 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 118 | $18.25 | $2,153.50 |
DisclosureSEC source: 0001992434-25-000004 · wk-form4_1758031948.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,732 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| September 15, 2025 Filed Sep 16, 2025 14:12 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 483 | $0.00 | $0.00 |
DisclosureSEC source: 0001992434-25-000004 · wk-form4_1758031948.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| June 15, 2025 Filed Jun 16, 2025 20:30 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 496 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000037 · wk-form4_1750105818.xml · derivative · entry 3 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 496 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on June 15, 2022 and vest on the third anniversary of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| June 15, 2025 Filed Jun 16, 2025 20:30 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 121 | $21.58 | $2,611.18 |
DisclosureSEC source: 0001142750-25-000037 · wk-form4_1750105818.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,367 F2 · kind: Shares withheld for tax purposes. Read SEC document |
| June 15, 2025 Filed Jun 16, 2025 20:30 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 496 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000037 · wk-form4_1750105818.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| May 02, 2025 Filed May 6, 2025 16:47 UTC |
Jones Daphne EDirector
|
GrantRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000030 · wk-form4_1746550048.xml · derivative · entry 1 Jones Daphne E · CIK 0001475924 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 16:47 UTC |
Huber Celia PDirector
|
GrantRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000027 · wk-form4_1746550015.xml · derivative · entry 1 Huber Celia P · CIK 0002066163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 16:47 UTC |
Trent-Adams SylviaDirector
|
GrantRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000029 · wk-form4_1746550037.xml · derivative · entry 1 Trent-Adams Sylvia · CIK 0001826381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 16:47 UTC |
FOLETTA MARK GDirector
|
GrantRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000028 · wk-form4_1746550025.xml · derivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 16:46 UTC |
HARRIS R JEFFREYDirector
|
GrantRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000026 · wk-form4_1746550004.xml · derivative · entry 1 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 16:46 UTC |
Hinton James H.Director
|
GrantRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000025 · wk-form4_1746549993.xml · derivative · entry 1 Hinton James H. · CIK 0001905630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the company. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 16:44 UTC |
Caballero Jorge A.Director
|
GrantRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000023 · wk-form4_1746549877.xml · derivative · entry 1 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 16:46 UTC |
Fontenot Teri G.Director
|
GrantRestricted Stock Units · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000024 · wk-form4_1746549982.xml · derivative · entry 1 Fontenot Teri G. · CIK 0001661066 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2025 Filed Apr 21, 2025 22:09 UTC |
Trent-Adams SylviaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000019 · wk-form4_1745273386.xml · derivative · entry 2 Trent-Adams Sylvia · CIK 0001826381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,019 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. Accordingly, the number of RSUs identified in this row vested on April 19, 2025. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2025 Filed Apr 21, 2025 22:09 UTC |
Trent-Adams SylviaDirector
|
Exercise / conversionCommon Stock | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000019 · wk-form4_1745273386.xml · nonDerivative · entry 1 Trent-Adams Sylvia · CIK 0001826381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN common stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 19, 2025 Filed Apr 21, 2025 22:08 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000018 · wk-form4_1745273333.xml · derivative · entry 2 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,019 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. Accordingly, the number of RSUs identified in this row vested on April 19, 2025. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2025 Filed Apr 21, 2025 22:08 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionCommon Stock | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000018 · wk-form4_1745273333.xml · nonDerivative · entry 1 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 19, 2025 Filed Apr 21, 2025 22:07 UTC |
FOLETTA MARK GDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000017 · wk-form4_1745273243.xml · derivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,019 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. Accordingly, the number of RSUs identified in this row vested on April 19, 2025. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2025 Filed Apr 21, 2025 22:07 UTC |
FOLETTA MARK GDirector
|
Exercise / conversionCommon Stock | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000017 · wk-form4_1745273243.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 19, 2025 Filed Apr 21, 2025 22:06 UTC |
Caballero Jorge A.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000016 · wk-form4_1745273169.xml · derivative · entry 2 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,019 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. Accordingly, the number of RSUs identified in this row vested on April 19, 2025. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2025 Filed Apr 21, 2025 22:06 UTC |
Caballero Jorge A.Director
|
Exercise / conversionCommon Stock | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000016 · wk-form4_1745273169.xml · nonDerivative · entry 1 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:53 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 79 | $25.84 | $2,041.36 |
DisclosureSEC source: 0001142750-25-000013 · wk-form4_1740448389.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,992 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:53 UTC |
Laughlin Whitney MChief Legal Officer
|
GrantCommon Stock | 264 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000013 · wk-form4_1740448389.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,071 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 15, 2022. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, annual year-over-year performance targets based, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") over a three-year period beginning on January 1, 2022 and ended December 31, 2024. As a result, 66% of the target amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:52 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 954 | $25.84 | $24,651.36 |
DisclosureSEC source: 0001142750-25-000012 · wk-form4_1740448316.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,708 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:52 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantCommon Stock | 2,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000012 · wk-form4_1740448316.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,662 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 15, 2022. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, annual year-over-year performance targets based, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") over a three-year period beginning on January 1, 2022 and ended December 31, 2024. As a result, 66% of the target amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:38 UTC |
Grace CarolineDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 77,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · derivative · entry 8 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,048 Underlying: Common Stock · 77,048 shares Expires not disclosed F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F8 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:38 UTC |
Grace CarolineDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 76,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · derivative · entry 7 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,569 Underlying: Common Stock · 76,569 shares Expires not disclosed F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Performance Restricted Stock Units ("PRSU") identified in this row were granted on January 15, 2024 and will be eligible for vesting based upon the achievement of a performance requirement. The ultimate number of PRSUs that can be deemed earned and vested under this award depends on the absolute total shareholder return for the period beginning on January 15, 2025 and ending on December 31, 2027. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:38 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · derivative · entry 6 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,652 Underlying: Common Stock · 10,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:38 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · derivative · entry 5 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,042 Underlying: Common Stock · 4,893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:38 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 2,512 | $26.12 | $65,613.44 |
DisclosureSEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · nonDerivative · entry 4 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,345 F2 · kind: Shares withheld for tax purposes. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:38 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · nonDerivative · entry 3 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:38 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,451 | $26.12 | $37,900.12 |
DisclosureSEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · nonDerivative · entry 2 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,194 F2 · kind: Shares withheld for tax purposes. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:38 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 4,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · nonDerivative · entry 1 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:37 UTC |
Laughlin Whitney MChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 10,719 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · derivative · entry 10 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,719 Underlying: Common Stock · 10,719 shares Expires not disclosed F8 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F9 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · derivative · entry 9 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 749 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: . The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 196 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · derivative · entry 8 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202 Underlying: Common Stock · 196 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · derivative · entry 7 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 138 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 223 | $26.12 | $5,824.76 |
DisclosureSEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 6 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,807 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 5 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 59 | $26.12 | $1,541.08 |
DisclosureSEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 4 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,281 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.